We found increased activity of the cytoskeletal-associated MARCKS protein in BRAF inhibitor-resistant melanoma cells compared to BRAF inhibitor-sensitive melanoma cells and explored the mechanism behind this increased activity. Here, BRAF is linked to melanoma.